44 results on '"Fancelli D"'
Search Results
2. 304 (PB084) - Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors
3. Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles
4. Thieno[3,2-c]pyrazoles a new class of Aurora inhibitors
5. 3-Amino-pyrrolo[3,4-c]pyrazoles: A new class of CDK2 inhibitors
6. Pirazoli Biciclici come Scaffold Comuni per l’Inibizione Selettiva di Aurora-A e/o CDK2
7. 3-Amino-pyrrolo[3,4-c]pyrazole: Design and validation of a novel, highly versatile scaffold for kinase inhibition
8. Design and Combinatorial Chemistry of Novel and Potent Aurora Kinase Inhibitors
9. Preparation of bicyclo-pyrazoles for treating diseases associated with altered kinase activity
10. AURORA-A T288E COMPLEXED WITH PHA-828300
11. ChemInform Abstract: Synthesis and Pharmacological Profile of FCE 28654: A Water-Soluble and Injectable ACAT Inhibitor.
12. Sintering Fundamentals of Magnesium Powders
13. Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358
14. Structure of Aurora-2 in complex with PHA-680626
15. Structure of Aurora-2 in complex with PHA-739358
16. 363 POSTER In vitro and in vivo molecular characterization of PHA-739358, an inhibitor of Aurora kinases
17. Aurora-2 T287D T288D complexed with PHA-680632
18. Serotoninergic 5-HT3 and 5-HT4 receptor activities of dihydrobenzofuran carboxylic acid derivatives
19. FCE 27677: A novel inhibitor of acyl-CoA:Cholesterol acyltransferase with potent oral hypolipidemic activity
20. Synthesis and pharmacological profile of FCE 28654: A water-soluble and injectable ACAT inhibitor
21. Potent and Selective Aurora Inhibitors Identified by the Expansion of a Novel Scaffold for Protein Kinase Inhibition
22. Homolytic aromatic alkylation of 1- and 2-alkoxynaphthalenes by manganese(III) oxidation of methanes or ethanes 1,1-disubstituted with electron-withdrawing groups
23. ChemInform Abstract: Manganese(III) Acetate-Induced Cyclization of α-Arylalkyl and α-(Aryloxy)alkyl β-Dicarbonyl Derivatives.
24. Serotoninergic 5-HT 3 and 5-HT 4 receptor activities of dihydrobenzofuran carboxylic acid derivatives
25. ChemInform Abstract: Synthesis and Pharmacological Profile of FCE 28654: A Water-Soluble and Injectable ACAT Inhibitor.
26. Solid phase synthesis of 2-substituted benzofurans via the palladium-catalysed heteroannulation of acetylenes
27. Systemic inhibition of acylCoA:cholesterol acyltransferase has lipid-normalizing effect in two hypercholesterolemic rabbit models
28. Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma.
29. A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins.
30. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
31. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis.
32. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
33. Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo.
34. Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.
35. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
36. PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.
37. Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358.
38. 6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitors.
39. 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.
40. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity.
41. 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors.
42. Correction of dyslipoproteinaemia of casein-fed rabbit by FCE 27677, a potent novel ACAT inhibitor.
43. FCE 27677: a novel inhibitor of acyl-CoA: cholesterol acyltransferase with potent oral hypolipidemic activity.
44. Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.